Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Neurotrophic Keratitis: Disease Classifications and Therapy Options

By: Francis S. Mah, MD (Moderator); Marjan Farid, MD; Stephen C. Pflugfelder, MD; Karolinne Maia Rocha, MD, PhD

Webinar Credits: 1.25

Eye care providers may not understand what neurotrophic keratitis is or how it differs from other corneal diseases. In addition; eye care practitioners may be unaware of treatments in development, or the already approved treatments for neurotrophic keratitis. They also may not understand the mechanism of action of these newer treatments.

This webinar features four experts in neurotrophic keratitis who will discuss disease classification, practice patterns, and traditional therapies, as well as clinical trial data on the latest treatments. The esteemed panel will also review and discuss select case studies.

Target Audience
This certified continuing medical education activity is designed for anterior segment specialists, general ophthalmologists, and other eye care providers involved in the management of corneal disorders.

Expiration Date: Wednesday, June 30, 2021
Release Date: July 8, 2020

Learning Objectives

At the completion of this educational activity, the participating ophthalmologist will be better able to:

Describe the stages of neurotrophic keratitis, and how to differentiate it from similar diseases.
Recognize the various potential causes of neurotrophic keratitis and when referrals may be necessary.
Summarize mechanisms of action of newer treatments and when they should be introduced into treatment regimens for neurotrophic keratitis.
Identify the relationships between disease characteristics, drug, treatment frequency, visual and anatomic outcomes.

 

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

 

Course Viewing Requirements

Supported Browsers:

Internet Explorer 11 for Windows

Edge (recent versions; Chromium-based) for Windows

Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux

Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux

Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:

4GB+ RAM

Recommended internet speed 5Mbps+

 

Faculty and Disclosures

Faculty:

 

Francis S. Mah, MD

Program Moderator
Director, Cornea and External Disease
Co-Director, Refractive Surgery
Scripps Clinic
La Jolla, CA

 

 

Marjan Farid, MD

Professor of Ophthalmology
School of Medicine
Vice Chair, Ophthalmic Faculty
Director, Cornea/External Disease,
Cataract, and Refractive Surgery
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA

 

 

Stephen C. Pflugfelder, MD

Professor of Ophthalmology
James and Margaret Elkins Chair
Director, Ocular Surface Center Baylor College of Medicine
Houston, TX

 

 

Karolinne Maia Rocha, MD, PhD

Director, Cornea & Refractive Surgery
Storm Eye Institute
Medical University of South Carolina
Charleston, SC

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Marjan Farid, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Biotissue, CorneaGen, Dompe, Johnson & Johnson Vision, and Novartis.

Francis S. Mah, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Dompé.

Stephen Pflugfelder, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan and Kala. Grant/Research Support: Allergan.

Karolinne Maia Rocha, MD, PhD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Ace Vision, Alcon, Allergan, Avedro, Bausch + Lomb, Dompé, and Johnson and Johnson Vision.

The Evolve staff and planners have no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Dompé.

Pretest

  • 1. Not at all confident2. Not very confident3. Neutral4. Confident5. Very confident

Video Resources

Next

Test

Instructions

Step 1 of 2

  • 1. Not at all confident2. Not very confident3. Neutral4. Confident5. Very confident
  • AgreeNeutralDisagree
    Describe the stages of neurotrophic keratitis (NK), and how to differentiate it from similar diseases.
    Recognize the various potential causes of NK and when referrals may be necessary.
    Summarize mechanisms of action of newer treatments and when they should be introduced into treatment regimens for NK.
    Identify the relationships between disease characteristics, drug, treatment frequency, visual and anatomic outcomes.
Back